A carregar...
Adaptive dose finding based on safety and feasibility in early-phase clinical trials of adoptive cell immunotherapy
BACKGROUND/AIMS: Dose feasibility is a challenge that may arise in the development of adoptive T cell therapies for cancer. In early-phase clinical trials, dose is quantified either by a fixed or per unit body weight number of cells infused. It may not be feasible, however, to administer a patient’s...
Na minha lista:
| Publicado no: | Clin Trials |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7211137/ https://ncbi.nlm.nih.gov/pubmed/31856602 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1740774519890145 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|